OTC Mevacor CUSTOM Label Illustrates New Approach Toward Approval
This article was originally published in The Tan Sheet
Executive Summary
Proposed labeling used in J&J/Merck's actual use trial for OTC Mevacor (lovastatin 20 mg) directs individuals to obtain follow-up cholesterol testing sooner than did the firm's 2000 proposal for the switch